Golden Biotechnology Corporation Reports Earnings Results for the Full Year Ended December 31, 2020
March 30, 2021 at 11:12 am EDT
Golden Biotechnology Corporation announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 88.825 million compared to TWD 83.293 million a year ago. Operating loss was TWD 347.935 million compared to TWD 270.458 million a year ago. Net loss was TWD 391.375 million compared to TWD 285.124 million a year ago. Basic loss per share was TWD 3.11 compared to TWD 2.48 a year ago.